Cancer Care Northwest

Hypermethylation of the caveolin‐1 gene promoter in prostate cancer

Cui Jiang, L. Ralph Rohr, Gregory P. Swanson et al. · The Prostate · 2001 · 125 citations

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer

Carryn M. Anderson, Christopher M. Lee, Deborah Saunders et al. · Journal of Clinical Oncology · 2019 · 119 citations · Full text

Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial

Rodney P. Rocconi, Elizabeth A. Grosen, Sharad Ghamande et al. · The Lancet Oncology · 2020 · 112 citations

Medicine, Immunology, Gynecology +6

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Jonathan Oh, Minal Barve, Carolyn M. Matthews et al. · Gynecologic Oncology · 2016 · 88 citations

Vigil® Dna, Medicine, Immunology +9

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

Robert M Eager, Casey Cunningham, Neil Senzer et al. · BMC Cancer · 2009 · 78 citations · Full text